Physician profile
Kimberly E Wright
NPI 1083784227
$1,483.95
in general payments reported to CMS, 2019-2025
25 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $147 · 2021: $280 · 2022: $210 · 2023: $132 · 2024: $293 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.96 | 2019-2025 | Liletta |
| Hologic Sales and Service, LLC | $224.59 | 2019-2024 | Affirm Prone Biopsy System |
| Coopersurgical, INC. | $131.85 | 2019-2025 | Paragard T 380a, Mara Console |
| Novo Nordisk INC | $110.93 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $82.16 | 2023-2024 | |
| Boston Scientific Corporation | $75.48 | 2025 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $57.97 | 2021-2024 | |
| Astellas Pharma US INC | $55.58 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $46.36 | 2019-2021 | |
| Evofem Biosciences, INC. | $43.42 | 2021-2022 | |
| Medtronic, INC. | $42.56 | 2021-2023 | Truclear |
| Exeltis, USA INC. | $37.51 | 2021-2024 | Slynd |
| Aspira Women'S Health INC | $36.37 | 2022-2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $36.22 | 2019 | |
| Dysis Medical, INC. | $33.66 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $31.22 | 2020-2021 | |
| Lilly USA, LLC | $25.47 | 2025 | Zepbound |
| Medicem INC. | $24.37 | 2020 | |
| Sumitomo Pharma America, INC. | $21.40 | 2024 | Myfembree |
| Exact Sciences Corporation | $18.07 | 2025 | |
| Olympus America INC. | $15.89 | 2019 | |
| Organon LLC | $15.06 | 2022 | |
| Medline Industries Lp | $14.70 | 2023 | |
| Mayne Pharma Commercial LLC | $13.83 | 2021 | |
| Myovant Sciences INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.